Insider · CIK 0001985443
Nataliya Agafonova
Files at LGVN (Longeveron Inc.). First filing -, latest -.
In brief
Nataliya Agafonova files SEC Form 4 as officer at LGVN (Longeveron Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nataliya Agafonova has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -2,913 | $2.59 | $7,545 | 68,778 | 9 d ago |
| Aug 19, 2026 | LGVN Longeveron Inc. | AGrant or award Class A Common Stock | +286,000 | $0.00 | $0 | 716,914 | Aug 21, 2026 |
| Jul 1, 2026 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -22,505 | $0.73 | $16k | 430,914 | Jul 6, 2026 |
| May 1, 2026 | LGVN Longeveron Inc. | AGrant or award Class A Common Stock | +250,000 | $0.00 | $0 | 453,419 | May 5, 2026 |
| Apr 1, 2026 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -13,145 | $1.12 | $15k | 203,419 | Apr 3, 2026 |
| Jan 2, 2026 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -10,250 | $0.59 | $6,078 | 216,564 | Jan 6, 2026 |
| Oct 1, 2025 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -11,883 | $0.74 | $8,822 | 226,814 | Oct 3, 2025 |
| Jul 15, 2025 | LGVN Longeveron Inc. | AGrant or award Class A Common Stock | +102,000 | $0.00 | $0 | 238,697 | Jul 17, 2025 |
| Jul 15, 2025 | LGVN Longeveron Inc. | AGrant or award Stock Option (right to buy)derivative | +34,000 | $0.00 | $0 | 34,000 | Jul 17, 2025 |
| Jul 1, 2025 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -7,431 | $1.28 | $9,512 | 136,697 | Jul 3, 2025 |
| Apr 1, 2025 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -7,566 | $1.50 | $11k | 144,128 | Apr 3, 2025 |
| Jan 2, 2025 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -6,120 | $1.79 | $11k | 151,694 | Jan 6, 2025 |
| Aug 15, 2024 | LGVN Longeveron Inc. | AGrant or award Class A Common Stock | +175,750 | $0.00 | $0 | 177,521 | Aug 19, 2024 |
| Aug 15, 2024 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -14,391 | $2.46 | $35k | 163,130 | Aug 19, 2024 |
| Aug 15, 2024 | LGVN Longeveron Inc. | AGrant or award Stock Option (right to buy)derivative | +16,250 | $0.00 | $0 | 16,250 | Aug 19, 2024 |
| May 2, 2024 | LGVN Longeveron Inc. | FTax withholding Class A Common Stock | -308 | $2.83 | $872 | 1,771 | May 6, 2024 |
| Jan 2, 2024 | LGVN Longeveron Inc. | FTax withholding Common Stock | -3,074 | $1.32 | $4,058 | 20,786 | Jan 25, 2024 |
Questions about Nataliya Agafonova
Answered from the filings on this page, as of the latest one.
Is Nataliya Agafonova buying or selling?
Nataliya Agafonova has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nataliya Agafonova's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nataliya Agafonova has 0.
Where does Nataliya Agafonova file Form 4?
Nataliya Agafonova has filed Form 4 at LGVN (Longeveron Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.